This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Thrombolysis  • Venous Thromboembolism  • Pediatrics  • Congenital Malformations  • Pediatrics, Other  • Pregnancy and Breast Feeding  • Adverse Effects  • Cardiovascular Intervention  • Alert me on articles by topic

Mike Mitka

JAMA. 2008;300(8):890.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Updated evidence-based guidelines for the prevention and management of thrombosis by the American College of Chest Physicians (ACCP) give more explicit directions for managing certain patient populations on long-term antithrombotic therapy, such as those facing surgery, those who are pregnant or considering becoming pregnant, and children.

Updated guidelines for preventing and treating thrombosis give more explicit directions for managing certain patient populations on long-term antithrombotic therapy. (Photo credit: Steve Gschmeissner/www.sciencesource.com)

The eighth edition of Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines was published as a 900-page supplement to the June issue of Chest (Hirsh J et al. Chest. 2008;133[6 suppl]67S-968S).

PERIOPERATIVE MANAGEMENT

For the first time, the ACCP guidelines dedicated a chapter to perioperative management of antithrombotic therapy. Jack Hirsh, MD, guidelines chair and professor emeritus in the Department of Medicine at McMaster University in Hamilton, Ontario, Canada, said previous editions . . . [Full Text of this Article]